1912 results about "Spot urine" patented technology

Examples relate to devices, systems, and methods for fluid collection such as urine. The urine collection device includes a fluid impermeable barrier and a fluid permeable body. The fluid impermeable barrier at least partially defines a chamber. The fluid impermeable barrier includes at least one elongated portion having a first width and distal to the aperture and a second portion having a second width greater than the first width. The second portion at least partially defines an opening in the fluid impermeable barrier, and the opening has a maximum lateral dimension greater than the first width of the elongated portion. The fluid permeable body is configured to wick fluid away from the opening into the at least one elongated portion.

Disclosed herein is a urine collection bag, system, and methods directed to automated measurement of a quantity of urine. The urine collection system can include the urine collection bag, a catheter, and flexible drainage tubing. The urine collection bag can include a collection area, force sensors, and circuitry configured to determine the volume of urine in the collection area based on pressure or weight measured by the force sensors, and the specific gravity of the urine. The catheter may include a small female external catheter (FEC) with an opening on a top side, a wicking catheter with a wicking area on a top side, a finger-mountable catheter, or a male external catheter (MEC). The tubing may be secured to a patient's leg with a stabilization device or a fabric strap. The catheter can remain on a patient while the patient stands or walks.

The invention discloses a blood, urine and body fluid collecting, detecting, analyzing and uploading system based on multi-sensor integration, which comprises the following modules: a blood collecting module for collecting a blood sample; the urine collection module is used for detecting urine; the body fluid collecting module is used for detecting body fluid; the data processing module is used for preprocessing data; the feature extraction and classification module is used for constructing a multi-modal feature matrix based on a neural structure search network, a support vector machine and a random forest algorithm; the anomaly detection module is used for generating a weighted anomaly score in combination with an isolated forest and a depth anomaly detection model; the time sequence analysis module is used for analyzing the health trend by using a variational auto-encoder-generative adversarial network; the health portrait and risk assessment module is used for constructing a health map by adopting a graph convolutional network; and the encryption and uploading management module is used for encrypting by using AES and RSA and managing the data access authority based on the intelligent contract. According to the invention, a multi-modal sensor and an intelligent algorithm are integrated, and collection, detection, analysis, encryption and uploading of blood, urine and body fluid are realized.

The invention belongs to the field of biomedicine, and particularly relates to application of CRYL1 protein in preparation of a product for evaluation, diagnosis or auxiliary diagnosis of postoperative recurrence risk of calcium oxalate kidney stone combined with renal nipple calcium spot, and the sequence of the CRYL1 protein is shown as SEQ ID NO.1. The invention discovers that the expression of the CRYL1 protein in renal tubules and collecting tube cells of renal papillary calcium spot tissues is reduced for the first time, and tests prove that the urine CRYL1 protein is a predictive factor and a predictive marker for postoperative recurrence of a patient with CaOx kidney stone combined with renal papillary calcium spot. The CRYL1 protein detection kit is further researched and developed to be used for detecting or evaluating the postoperative recurrence risk of patients suffering from CaOx kidney stone combined with renal nipple calcium spots, personalized follow-up visit and prevention schemes of the patients are promoted, and the CRYL1 protein detection kit has huge clinical application prospects.

Examples relate to systems, devices, and methods for removing fluid from a fluid collection device using a vacuum source operably coupled thereto. The fluid collection devices include urine collection devices having shape memory material that may be selectively shaped to complement the female or male anatomy near the respective urethras.

Disclosed are automated urinary output (“UO”)-measuring systems and methods. An automated UO-measuring system can include a container configured to collect a fluid such as urine. The container can include a console, one or more ultrasonic sensors coupled to the console for determining a fluid level within the container, one or more accelerometers coupled to the console for determining a near-zero acceleration state of the container for the determining of the fluid level within the container, and a valve configured to pass fluid therethrough by way of a fluid line coupled to the valve. The automated UO-measuring system can also include a container holder. The container holder can have a pocket for holding the container and a sleeve for securing the container to a user. A method of the automated UO-measuring system can include a method of using the automated UO-measuring system to collect and measure urine output of the user.

Devices, methods and systems are disclosed for monitoring and analysis of bodily emissions emitted from a user. The device comprises at least an image capturing apparatus, at least one light emission source and, at least one sensor for capturing and monitoring excreta and urine from the user. An artificial intelligence based analysis system is utilized to process data collected from the device and determined at least one parameter based on the analysis. The determined parameter determines health-related information, which is communicated to the user via a user interface.

The ureter and urine bag comprises a urine bag body, a spiral pipe, a connecting pipe, a threaded connector pipe and a urine guiding pipe, the threaded connector pipe comprises a pipe body and an insertion pipe, internal threads with the thread pitch being 1.8-2.2 mm are machined on the inner wall of the pipe body, external threads matched with the internal threads are machined on the outer wall of the insertion pipe, and the spiral pipe is connected with the connecting pipe. Two groups of wing plates are symmetrically arranged on the outer wall of the cannula to provide rotating acting points, and a collecting assembly is integrated on the side wall of the urine bag and used for aseptically collecting urine samples. Traditional plug-pull type connection is replaced by a precise thread fit structure, a clear rotating force application point is provided for medical staff, operation is labor-saving and convenient, connector pollution is avoided, the urinary tract infection risk is effectively reduced, and the nursing comfort of a patient is improved.

The invention discloses a sepsis-related acute kidney injury intelligent prediction system and a hierarchical management method, and the system comprises a multi-modal data collection module which synchronously collects an ultrasound contrast video, a urine biomarker and hemodynamic parameters in real time; the spatio-temporal feature extraction module is used for extracting multi-modal spatio-temporal features; modeling a dynamic interaction effect of heart and kidney nodes through a dynamic organ interaction graph network; the self-supervised pre-training module is used for improving the generalization of the model through comparative learning; the dynamic risk prediction module outputs a risk probability curve in the next 24 hours; the hierarchical decision management module is used for generating personalized strategies of liquid management, vasoactive drug adjustment and kidney replacement treatment opportunity; and the interpretability module is used for analyzing the key early warning characteristics based on the SHAP value. According to the method, the problems of deficiency of organ interaction modeling, poor generalization of small samples, stiffness of static decision and the like are solved, and the early warning and precise treatment capabilities of the sepsis-related kidney injury are remarkably improved.

The invention discloses midstream urine collection equipment with high sealing performance, belongs to the technical field of midstream urine collection, and aims to solve the problems that a patient cannot accurately control the urination rhythm, so that the boundary between forepart urine and midstream urine is fuzzy, the collected midstream urine contains part of forepart urine, and the midstream urine collection accuracy is influenced. A fixing frame is fixed to the inner side wall of the collecting hopper, a contact plate is arranged on one side of the fixing frame, four evenly-distributed positioning columns are fixed to the side, close to the fixing frame, of the contact plate, and the positioning columns are movably connected to one side face of the fixing frame; after the contact plate is impacted by urine, impact force can be transmitted to the pressure sensor, the impact force of the urine can be detected through the arranged pressure sensor, and then the pressure sensor is matched with the PLC to distinguish anterior urine, midstream urine and posterior urine, so that the boundary distinguishing between the midstream urine and the anterior urine is obvious, and the accuracy of urine detection is improved. The problem that the accuracy of midstream urine collection is affected due to the fact that the collected midstream urine contains part of anterior urine due to autonomous judgment of a patient is avoided.

A station for a urine analysis device is proposed, the station including a case, intended to be positioned at least partially within the toilet, a housing, within the case, configured to at least partially receive a cartridge comprising a plurality of test supports (e.g. test strips). The cartridge is movable within the housing. The station may also include an optical sensor, a translatory injector and an analyzer (e.g. optical). Various configurations are available.

The invention provides a diabetic nephropathy early warning method, system, equipment and medium, and relates to the technical field of medical data analysis and prediction.The method comprises the steps that multiple urine samples of a user are collected, target urine protein detection is conducted, and multiple urine protein concentrations are obtained; each urine protein concentration is combined with a normal urine protein concentration set to be input into an abnormal data recognition tree, the number of layers of multiple recognition nodes is obtained, and the detection confidence coefficient is obtained through calculation; configuring an abnormal proportion according to the detection confidence coefficient, inputting a plurality of urine protein concentration combination normal urine protein concentration sets into an abnormal data identification tree, deleting urine protein concentrations divided into abnormal data in the abnormal proportion before, and obtaining screened urine protein concentrations; according to the screened urine protein concentration, an auxiliary early warning coefficient is obtained through calculation, and early warning is carried out. The technical problem of low early warning accuracy of diabetic nephropathy in the prior art is solved.

The present invention belongs to the field of medical instruments. Disclosed is a pressure-relief urine bag, comprising: a bag internally provided with a urine storage cavity, wherein an input tube communicating the outside with the urine storage cavity is provided on the bag, and fluid can enter the urine storage cavity through the input tube, but the fluid in the urine storage cavity cannot be drained through the input tube; a warning structure comprising a pressure-sensing member and a vibration member, wherein the pressure-sensing member is electrically connected to the vibration member, the warning structure is connected to the bag, the pressure-sensing member is located in the urine storage cavity, and when the occupied space in the urine storage cavity reaches a set value, the fluid presses the pressure-sensing member and causes the vibration member to vibrate and produce sound; and an output tube, which is connected to the bag at one end, and comprises a manual urine drainage tube and an automatic urine drainage tube, wherein one end of the manual urine drainage tube is in communication with the urine storage cavity. The present invention can alert a patient and medical staff when the urine bag is about to be full of urine, and even if the patient and medical staff fail to notice and allow the urine bag to fill up, the urine in the bag can still be drained through the automatic urine drainage tube, thereby effectively preventing leakage or bursting caused by excessive pressure in the urine bag.

Disclosed here are kits comprising pre-packed stabilizing solutions for stabilizing combinations of biomarkers demonstrating sufficient accuracy and specificity for identifying kidney injuries. Such kits can be better adapted for sample collection at a subject's dwelling, thus easing the burdensome requirement of continuous monitoring for kidney injury.

Doubly labeled water with enhanced protocol. One embodiment is a method including providing, to a user, a doubly labeled water (DLW) dose for the user to ingest, the DLW dose including deuterium and oxygen-18, wherein an amount of the deuterium is less than 0.12 grams per kilogram (g / kg) of body water of the user, and wherein an amount of the oxygen-18 is less than 0.18 g / kg of body water of the user. The method also includes receiving, from the user, a non-cooled shipment of urine samples collected in connection with ingestion of the DLW dose, wherein the urine samples remain uncooled after collection and during transit for a period of up to 24 days. The method further includes processing the urine samples with a liquid water isotope analyzer to determine one or more metabolic parameters of the user.

The invention relates to methods, devices, and software for distinguishing hemoglobin (Hb) from myoglobin (Mb) in urine samples using peroxidase-reactive test strips. A time-resolved video of the color change on the test pad is recorded, and hue values are extracted and analyzed over time. Diagnostic differentiation between Hb and Mb is achieved by evaluating the hue-time curve, in particular via endpoint hue values and the ratio of integrated hue values in distinct time intervals. The invention further comprises a standardized optical setup for recording, a software-based evaluation algorithm, and a refillable cartridge for in-situ urine analysis devices containing appropriate test fields. The invention enables combined testing with additional urine parameters and is suitable for medical and non-clinical applications such as sport and home diagnostics.

A urine management device includes a collection chamber hingedly coupled to a base. The base includes a proximal side and a distal side. The proximal side of the base is configured to contact a pelvic area of a user and the distal side faces the collection chamber. During application, the collection chamber can be folded out of the way, allowing a clinician full access to adhere the base to the pelvic area of the user. Once the base is securely adhered to the pelvic area of the user, the collection chamber can be folded back and coupled to the distal side of the base, creating a secure seal. The collection chamber is configured to (i) collect urine exiting an anatomy of the user and (ii) direct the urine in the collection chamber toward an outlet.

The invention relates to the technical field of medical health monitoring, and discloses a urine volume detection system based on a strain gauge type sensor, which comprises a urine collection container, a strain gauge type sensor, an electromagnetic valve, a main controller and an infrared human body sensor, the upper port of the urine collecting container is used for receiving urine, and the lower port of the urine collecting container is connected with the strain gauge type sensor; the strain gauge type sensor is used for detecting the weight change of the urine collection container, the urine volume detection system based on the strain gauge type sensor and the intelligent closestool overcome the defect that a traditional closestool cannot measure and record the urine volume, convenience is brought to patients who do not want to use a urinal or a pedestal pan and old people with poor eyesight, and the intelligent closestool is convenient to use. A user can know the urine volume when using the closestool or pouring urine into the urinal into the closestool, use is convenient and sanitary, accurate urine volume data helps a doctor to formulate a more accurate medication scheme for a patient, and the patient is prevented from seeing a doctor repeatedly and the health risk caused by medicine problems.

There is a provided a urine collection device for collecting an uncontaminated urine sample from a pre-continent or an incontinent user, the urine collection device comprising: a receptacle configured to be placed within a nappy or an incontinence pad of the user to receive and retain a urine sample collected from the user in use, wherein the receptacle comprises: a receiving portion for receiving the urine sample, the receiving portion comprising an opening configured to engage with a human body portion surrounding external genitalia of the user, thereby enabling urine exiting the body of the user to be captured directly in use; a reservoir for retaining the received urine sample in use; and an outlet for draining the retained urine sample in use, wherein the opening is larger than the outlet.

An intermittent catheter package including a plurality of components and a catheterization tray configured to facilitate a catheterization procedure. The plurality of components include a urinary catheter fluidly connected to a urine-drainage bag and a sampling-port access device configured to fluidly connect to a urine-sampling port of the urinary catheter or the urine-drainage bag for aseptic collection of one or more urine samples.The catheterization tray includes at least a first compartment, a second compartment, a third compartment, and a fourth compartment. The second compartment is connected to the third compartment Step-by-step surface instructions for performing the catheterization procedure are incorporated into the catheterization tray.

Disclosed herein is a urine collection bag, system, and methods directed to automated measurement of a quantity of urine. The urine collection system can include the urine collection bag, a catheter, and flexible drainage tubing. The urine collection bag can include a collection area, force sensors, and circuitry configured to determine the volume of urine in the collection area based on pressure or weight measured by the force sensors, and the specific gravity of the urine. The catheter may include a small female external catheter (FEC) with an opening on a top side, a wicking catheter with a wicking area on a top side, a finger-mountable catheter, or a male external catheter (MEC). The tubing may be secured to a patient's leg with a stabilization device or a fabric strap. The catheter can remain on a patient while the patient stands or walks.

The invention relates to the technical field of medical examination, in particular to a sectional urine sampling device applicable to medical examination, which comprises a urine sampling module, the urine taking module is divided into a urine dividing mechanism, a flow dividing mechanism, a sampling mechanism and a processing mechanism which are sequentially distributed from top to bottom, an operation panel is installed at the top of the urine dividing mechanism, the outer side of the urine dividing mechanism is communicated with a disinfection pipe, the other side of the disinfection pipe extends into the disinfection box to be communicated with a pump body, and the pump body is arranged in the disinfection box containing disinfectant; the outer side of the urine distribution mechanism is also fixedly connected with a slow air suction mechanism for exhausting air and a horizontally arranged hanging frame; the whole section of urine can be completely collected through the arranged urine taking module, the whole section of urine can be automatically divided into the front section of urine, the middle section of urine and the rear section of urine when the urine is discharged into the urine dividing mechanism, then the urine in the optimal time period is selected according to the actual situation, and it is ensured that detection data are accurate.

The invention discloses a method for extracting mesenchymal stem cells from urine. The method comprises the following steps: (1) sampling and inoculating urine; (2) amplification and passage of mesenchymal stem cells; (3) identifying the urine stem cells; and (4) a cryopreservation and resuscitation method of the urine stem cells. And performing biological phenotype identification according to the standard formulated by the International Cell Therapy Association to confirm the mesenchymal stem cells. The method is low in cost, simple and rapid, and the used culture solutions are all commercialized and are very convenient to purchase and use. The culture solution special for the stem cells is used in the first two weeks of the extraction period, after passage, when enough stem cells are obtained, the culture medium can be replaced with a common DMEM culture medium, and the manufacturing cost is greatly reduced. And secondly, the materials are simple, rapid and non-invasive, and the sample of the method for extracting the mesenchymal stem cells from urine comes from a patient, so that the problem of heterogeneity of cell sources is reduced. And a foundation is laid for stem cell treatment and gene editing treatment of genetic diseases and major difficult diseases.

The invention relates to a urine specific protein detection sample quality screening system and screening method. The screening method comprises the following steps: firstly, creating a urine specific protein quality model; then collecting an image of a to-be-detected sample; and finally, analyzing and evaluating the sample to be detected according to the sample quality model and the image of the sample to be detected, and converting urine colors (such as light yellow, deep yellow, hematuria and the like) into quantifiable numerical values by collecting the image of the sample (urine). Compared with traditional naked eye observation, judgment deviation caused by subjective factors such as experience and ambient light of detection personnel is avoided, and the detection result is more objective and repeatable; according to the method, the sample image is converted into quantifiable numerical values so as to carry out numerical analysis on the detection data of the color, clarity and turbidity of the sample, hematuria and urine with high turbidity in the sample are automatically screened out, manual operation steps are reduced, the detection efficiency is improved, and the method is particularly suitable for clinical or large-scale screening scenes.

The invention relates to a method for removing a chemical substance from human excreta, such as faeces and urine, comprising the following steps of: providing a toilet for a person from whose excreta the chemical substance must be removed; releasably connecting a filtering device to the toilet, wherein the filtering device comprises at least one removable cartridge with a filter; transporting the excreta by means of a transport screw from the toilet toward the filter in the cartridge, wherein pressure is exerted on the excreta by means of a plunger; filtering the chemical substance out of the excreta in situ using the filtering device; periodically replacing the at least one cartridge; and processing the replaced cartridge. The invention also relates to a filtering device for application in this method, and a cartridge for use in such a filtering device.

The present invention provides a kit and a detection method for synchronously detecting catecholamines and their metabolites, which relates to the technical field of analytical detection. The kit contains a diluent, a solid-phase extraction reagent, an LC-MS / MS detection reagent, a solid-phase extraction device, and a solid-phase extraction packing material. Among them, the solid-phase extraction packing material creatively adopts zwitterionic exchange microspheres containing both carboxyl and quaternary ammonium groups. The kit can not only synchronously and efficiently separate and detect 8 kinds of catecholamines and their metabolites in urine samples, but also separate and detect 6 kinds of amino-containing catecholamines and their metabolites in blood samples. When the above kit is used to separate and detect catecholamines and their metabolites, the extraction recovery rate is relatively high, and the linear range covers the reference value range of normal detection, which can significantly shorten the detection time of urine samples, improve the detection efficiency of mass spectrometry, and is conducive to popularization and application in clinical detection.

The present application provides a urine processing method and a urine testing system. The method comprises processing urine to obtain urinary sediment and supernatant, performing crystallization processing on the supernatant and making analysis to obtain supernatant-related parameters, and making comprehensive analysis through combination of the supernatant-related parameters with urinary sediment-related parameters and urine dry chemistry-related parameters. The system comprises a urine processing module configured to process urine to obtain urinary sediment and supernatant, and a supernatant analysis module configured to perform crystallization processing on the supernatant and make analysis to obtain supernatant-related parameters, and to make comprehensive analysis through combination of the supernatant-related parameters with the urinary sediment-related parameters and the urine dry chemistry-related parameters.

Devices, methods and systems are disclosed for monitoring and analysis of bodily emissions emitted from a user. The device comprises at least an image capturing apparatus, at least one light emission source and, at least one sensor for capturing and monitoring excreta and urine from the user. An artificial intelligence based analysis system is utilized to process data collected from the device and determined at least one parameter based on the analysis. The determined parameter determines health-related information, which is communicated to the user via a user interface.

The invention discloses a high-precision real-time urodynamic monitoring method and system, and belongs to the technical field of medical monitoring. A urine flow sensor is arranged at the downstream of a catheterization assembly to collect urine flow and generate an electric signal; the electric signals are transmitted to a micro-control unit for digital processing, and the instantaneous flow velocity of urine, the accumulated urine volume per hour and the total urine volume of 24 hours are calculated in real time through an integral flow velocity algorithm; a calculation result is output to a local display screen, and real-time data viewing and historical curve graph and statistical report display are supported; meanwhile, the urine volume data are packaged according to timestamps and patient identifications and uploaded to a hospital nursing information system through a standardized interface protocol; if it is detected that the urine volume is abnormally lower than a set threshold value or is completely in a urine-free state, the system automatically triggers an alarm and pushes the alarm to the nursing terminal; by means of the method, automation, informatization and intelligentization of urine volume monitoring can be achieved, and the method is suitable for continuous nursing requirements of ICU and other critical areas.

The invention discloses a urine collection and storage device, and relates to the technical field of urine collection devices, the urine collection and storage device comprises a base frame for receiving urine and a liquid guide channel fixedly arranged on the base frame, the base frame is provided with a floating collection mechanism for quantitatively collecting urine at the middle end, and the floating collection mechanism comprises a horizontal base fixedly connected to the inner wall of the base frame; the horizontal base is provided with a horizontal assembly for adjusting the relative position of the transverse base and the liquid guide channel, the two horizontal sides of the middle clamping base are provided with a main inner cavity column and a slave inner cavity column respectively, and the partition frame is provided with a blocking assembly for partitioning and sealing the internal space of the main inner cavity column and the slave inner cavity column. By arranging the floating collection mechanism, midstream urine of a patient can be accurately collected, and meanwhile, tissues and impurities deposited at the bottom of a urine bag are abandoned, so that the purity and representativeness of a urine sample are effectively improved, the accuracy of a detection result is ensured, and the misdiagnosis risk caused by sample pollution or impurity mixing is reduced.